Rahul M Ladwa

9PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumoursNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 01, 2026
Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review.

|Jul 21, 2025
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study.

Rahul Ladwa, Jenny H Lee, Margaret McGrath

|May 22, 2025
Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity.

Benedict J Panizza, Stephen John O'Leary, Christopher David Hart

|Feb 27, 2025
A Proteomic Signature for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence.

Christopher C Jackson, Jia Jenny Liu, Howard Y Liu

|Dec 08, 2023
Audiological ototoxicity monitoring guidelines: a review of current evidence and appraisal of quality using the AGREE II tool.

Georgia M Lester, Wayne J Wilson, Barbra H B Timmer

|Jun 10, 2022
Understanding the tumor microenvironment in head and neck squamous cell carcinoma.

Habib Sadeghi Rad, Yavar Shiravand, Payar Radfar

Pageof 2

Frequent Collaborators

4 joint publications

Benedict Panizza

2 joint publications

Howard Y Liu

2 joint publications

Margaret McGrath

2 joint publications

Sandro V Porceddu